Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Rallybio Holdings LLC

RLYB
1,525
0,045 (3,04%)
10 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/5/202422:22EDGAR2Form 8-K - Current report
21/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
17/5/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:02EDGAR2Form S-3 - Registration statement under Securities Act of..
09/5/202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:11EDGAR2Form 8-K - Current report
09/5/202414:00BWRallybio Reports First Quarter 2024 Financial Results and..
07/5/202414:00BWRallybio to Present at the 2024 Citizens JMP Life Sciences..
17/4/202422:01BWFNAIT Systematic Literature Review and Meta-Analysis..
10/4/202422:01BWRallybio Announces Collaboration to Advance Therapeutic..
01/4/202416:05BWRallybio Announces FNAIT Systematic Literature Review to be..
12/3/202413:00BWRallybio Reports Fourth Quarter and Full Year 2023 Financial..
26/2/202414:00BWRallybio to Present at the TD Cowen 44th Annual Health Care..
17/2/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202414:15EDGAR2Form 8-K - Current report
06/2/202414:00BWRallybio Announces Portfolio Prioritization and Provides..
04/1/202414:00BWRallybio Highlights Portfolio Advances and Outlines Expected..
20/12/202314:15EDGAR2Form 8-K - Current report
20/12/202314:00BWRallybio Announces Preliminary Phase 1 Multiple Ascending..
09/12/202318:00BWRallybio Presents Natural History Study for Fetal and..
28/11/202313:00BWRallybio Announces Preliminary Multiple Dose Data from the..
09/11/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202314:10EDGAR2Form 8-K - Current report
09/11/202314:00BWRallybio Reports Third Quarter 2023 Financial Results and..
08/11/202314:00BWRallybio to Present at Upcoming Investor Conferences in..
02/11/202314:15BWRallybio Announces Acceptance of FNAIT Natural History Study..
03/10/202314:00BWRallybio to Present at the JonesTrading 2023 Healthcare..
03/9/202318:00BWRallybio Presents Phase 1 Single Ascending Dose Data for..
31/8/202314:00BWRallybio to Present at Upcoming Investor Conferences in..
08/8/202322:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202314:16EDGAR2Form 8-K - Current report
08/8/202314:00BWRallybio Reports Second Quarter 2023 Financial Results and..
02/8/202314:00BWRallybio to Present at the 2023 Wedbush PacGrow Healthcare..
11/7/202314:00BWRallybio Announces Acceptance of Abstract for RLYB116 at the..
29/6/202313:30EDGAR2Form 8-K - Current report
29/6/202313:00BWRallybio Announces Succession Plan; Appoints Stephen Uden,..
24/6/202321:30BW Rallybio Announces Proof-of-Concept Results and Development..
Apertura: 1,45 Min: 1,44 Max: 1,55
Chiusura: 1,48

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network